Finnpipette BioControl Multichannel, 8 Channel 5-50ul from Thermo Scientific
Acl I (Psp1406 I) from New England Biolabs
Mouse Anti-Human Cystatin A Monoclonal Antibody, Unconjugated, Clone 224705 from R&D Systems
Acc I from Takara Mirus Bio
Biology Products:...y Assistance (AOA), a comprehensive, multi-faceted..."cap" on out-of-pocket co-payments for cancer pati...h AOA, patients who are uninsured, underinsured, o...l receive help obtaining financial support for Amg...ng cancer is expensive and our industry needs to f...
...ully so your buddy can get some tail may seem like...rds, it also gives a fascinating peek into hard-wi...hed lizards spend their year on earth looking to r...evolution. An article in the May 9 edition of the ...ovides the first genetic evidence of a trait that ...
...oteins in the brains of individuals addicted to co...nd mechanisms that may one day lead to new treatme...rted in the current issue of Molecular Psychiatry,...mounts of 50 proteins and point to profound change...se, said Scott E. Hemby, Ph.D., of Wake Forest Uni...
Other Biology News:Amgen introduces comprehensive financial assistance programs for cancer patients 2Nice guys do finish first in lizards' evolutionary race 2High-tech research shows cocaine changes proteins and brain function 2(Date:11/6/2009)...Intarcia Therapeutics, Inc. delivered two presenta...s delivery of exenatide) program for the treatment...echnology Meeting in San Francisco, CA: ,, (Log...FTU126LOGO ) ,, Continuous Subcutaneous Deliv...e, HbA1c and Reduces Weight in a 28-day Phase 1b S...
(Date:11/5/2009)... DSM Pharmaceutical Products today announced that ... Saint Jean D,Illac, France, where DSM will be the...for Galenix commercial products on a global basis....s development opportunities co-marketing Galenix d...f Galenix in drug product development and clinical...
(Date:11/5/2009)...Call/ -- BioSpecifics Technologies Corp. (Nasdaq: ...rst-in-class collagenase-based products, today ann... ended September 30, 2009. ,, "We were extreme...s Arthritis Advisory Committee unanimously recomme...M) for the treatment of Dupuytren,s disease, and w...
(Date:11/5/2009)...ineSmith Partners has signed an initial agreement ...d that mimics the structure of natural cancellous ...products by SpineSmith,s Research and Development ...fold represents a significant advancement in techn...for the delivery of adult stem cells for skeletal ...
Breaking Biology Technology:Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 2DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 3BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5SpineSmith Partners and GenOsteo Announce Collaborative Product Development Agreement 2